Wen‐Chun Liu

11.1k citations

148 papers · 5.1k indexed · 1 hit paper · h-index 28

Co-authors: Randy A. Albrecht Jean K. Lim Tristan X. Jordan Taia T. Wang Kohei Oishi Maryline Panis Robert E. Schwartz Daniel Blanco-Melo
Topics: Hepatitis C virus research (43 papers)Hepatitis B Virus Studies (38 papers)HIV/AIDS drug development and treatment (37 papers)
Cited by: Infectious Diseases Virology Hepatology
Journals: Cell Journal of Clinical Investigation PLoS ONE
Partner nations: Taiwan United States China

In The Last Decade

Wen‐Chun Liu

142 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

2020 2.7k citations Wen‐Chun Liu, Randy A. Albrecht et al. profile →

Peers

Countries citing papers authored by Wen‐Chun Liu

Since Specialization

Citations

This map shows the geographic impact of Wen‐Chun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Chun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Chun Liu more than expected).

Fields of papers citing papers by Wen‐Chun Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Chun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Chun Liu. The network helps show where Wen‐Chun Liu may publish in the future.

Co-authorship network of co-authors of Wen‐Chun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Chun Liu. A scholar is included among the top collaborators of Wen‐Chun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Chun Liu. Wen‐Chun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduction of pesticides and bacteria on Napa cabbage by ozone microbubble water 2023 ·Postharvest Biology and Technology ·Hsiu‐Ling Chen,(unknown),Peiyu Liao,Chih‐Yao Hou,Wen‐Chun Liu,Yun‐Ru Chen,Jong‐Shinn Wu,(unknown),Chia‐Min Lin	9
2	Characterization of microbial contamination of retail washed and unwashed shell eggs in Taiwan 2023 ·Food Control ·(unknown),Hsiu‐Ling Chen,(unknown),Wen‐Chun Liu,(unknown)	5
3	A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination 2023 ·Clinical Infectious Diseases ·Guan‐Jhou Chen,Hsin‐Yun Sun,Kuan‐Yin Lin,Szu‐Min Hsieh,Yu‐Chung Chuang,Wang-Da Liu,Yu‐Shan Huang,Sung‐Ching Pan,Un‐In Wu,Aristine Cheng,Yi‐Chia Huang,(unknown),Yi‐Ching Su,Wen‐Chun Liu,Sui‐Yuan Chang,Chien‐Ching Hung	3
4	Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine 2022 ·Microbiology Spectrum ·Aitor Nogales,John Steel,Wen‐Chun Liu,Anice C. Lowen,Laura Rodríguez,Kevin Chiem,(unknown),Adolfo Garcı́a-Sastre,Randy A. Albrecht,Stephen Dewhurst,Luis Martínez‐Sobrido	5
5	Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study 2022 ·Open Forum Infectious Diseases ·Chen‐Hua Liu,Hsin‐Yun Sun,Cheng‐Yuan Peng,Szu‐Min Hsieh,Sheng‐Shun Yang,Wei‐Yu Kao,Yu‐Lueng Shih,Chih‐Lin Lin,Chun‐Jen Liu,(unknown),Yi‐Chun Lo,Wen‐Chun Liu,Jo‐Hsuan Wu,Tung‐Hung Su,Tai‐Chung Tseng,Pei‐Jer Chen,Chien‐Ching Hung,Jia‐Horng Kao	10
6	Tox2 is required for the maintenance of GC T _FH cells and the generation of memory T _FH cells 2021 ·Science Advances ·Shu Horiuchi,(unknown),Wen‐Chun Liu,Nathalie Schmitt,(unknown),Yang Liu,Salah-Eddine Bentebibel,Randy A. Albrecht,Michael Schotsaert,Christian V. Forst,Bin Zhang,Hideki Ueno	21
7	Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy 2021 ·International Journal of Infectious Diseases ·Guan‐Jhou Chen,Hsin‐Yun Sun,Sui‐Yuan Chang,Aristine Cheng,Yu‐Shan Huang,Sung‐Hsi Huang,Yi‐Chia Huang,Yi‐Ching Su,Wen‐Chun Liu,Chien‐Ching Hung	17
8	Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model 2021 ·Vaccines ·Wen‐Chun Liu,Raffael Nachbagauer,Daniel Stadlbauer,Shirin Strohmeier,Alicia Solórzano,(unknown),Bruce L. Innis,Adolfo Garcı́a-Sastre,Peter Palese,Florian Krammer,Randy A. Albrecht	17
9	A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine 2020 ·Vaccines ·Weina Sun,Stephen McCroskery,Wen‐Chun Liu,Sarah R. Leist,(unknown),Randy A. Albrecht,Stefan Slamanig,Justine Oliva,Fatima Amanat,Alexandra Schäfer,Kenneth H. Dinnon,Bruce L. Innis,Adolfo Garcı́a-Sastre,Florian Krammer,Ralph S. Baric,Peter Palese	59
10	Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells 2019 ·Journal of Virology ·Ariel Rodríguez-Frandsen,Laura Martin‐Sancho,Anshu P. Gounder,Max W. Chang,Wen‐Chun Liu,Paul D. De Jesus,(unknown),Míriam Santos Dutra,(unknown),(unknown),Ignacio Mena,Laura Riva,Courtney Nguyen,(unknown),Kristina M. Herbert,Christopher Benner,Randy A. Albrecht,Adolfo Garcı́a-Sastre,Sumit K. Chanda	3
11	Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide 2019 ·International Journal of Infectious Diseases ·(unknown),Hsin‐Yun Sun,Yu‐Chung Chuang,Pei‐Ying Wu,Wen‐Chun Liu,Chien‐Ching Hung	48
12	Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance 2018 ·Journal of Clinical Investigation ·Sean Liu,Mohammad Amin Behzadi,Weina Sun,Alec W. Freyn,Wen‐Chun Liu,Felix Broecker,Randy A. Albrecht,Nicole M. Bouvier,Viviana Simon,Raffael Nachbagauer,Florian Krammer,Peter Palese	55
13	A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies 2017 ·npj Vaccines ·Raffael Nachbagauer,Wen‐Chun Liu,Angela Choi,Teddy John Wohlbold,(unknown),Madhusudan Rajendran,Alicia Solórzano,(unknown),Adolfo Garcı́a-Sastre,Peter Palese,Randy A. Albrecht,Florian Krammer	113
14	Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study 2016 ·Journal of Microbiology Immunology and Infection ·Mao‐Song Tsai,Sui‐Yuan Chang,Shu‐Wen Lin,Ching‐Hua Kuo,Hsin‐Yun Sun,Bing‐Ru Wu,(unknown),Wen‐Chun Liu,Yi‐Ching Su,Chien‐Ching Hung,Shan‐Chwen Chang	6
15	Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design 2016 ·Antiviral Research ·Wen‐Chun Liu,(unknown),Ting‐Hsuan Chen,Chia‐Chyi Liu,Jia‐Tsrong Jan,Suh‐Chin Wu	8
16	Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy 2015 ·PLoS ONE ·Kuan‐Yin Lin,Sih‐Han Liao,Wen‐Chun Liu,Aristine Cheng,Shu‐Wen Lin,Sui‐Yuan Chang,Mao‐Song Tsai,Ching‐Hua Kuo,(unknown),Hsiu-Po Wang,Chien‐Ching Hung,Shan‐Chwen Chang	10
17	Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy 2015 ·Journal of Microbiology Immunology and Infection ·(unknown),Hui‐Wen Lin,Chia‐Jui Yang,Mao-Yuan Chen,Wang‐Huei Sheng,Wen‐Chun Liu,Sui‐Yuan Chang,Chien‐Ching Hung,Po‐Ren Hsueh,Shan‐Chwen Chang	4
18	Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan 2015 ·BMJ Open ·(unknown),Chien‐Ching Hung,Sui‐Yuan Chang,Wen‐Chun Liu,(unknown),Yi‐Ching Su,Pei-Ying Wu,(unknown),(unknown),Hsin‐Yun Sun,Shan‐Chwen Chang	14
19	Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07 _– BC Infection in Intravenous Drug Users 2006 ·AIDS Research and Human Retroviruses ·Sui‐Yuan Chang,Wang‐Huei Sheng,Chun‐Nan Lee,Hsin‐Yun Sun,Chuan‐Liang Kao,(unknown),Wen‐Chun Liu,(unknown),Wing-Wai Wong,Chien‐Ching Hung,Shan‐Chwen Chang	21
20	Identification of A Ribavirin–Resistant Ns5b Mutation of Hepatitis C Virus During Ribavirin Monotherapy 2003 ·Hepatology ·Kung-Chia Young,Karen L. Lindsay,(unknown),Wen‐Chun Liu,Jianwen He,(unknown),Michael M. C. Lai	107

About Wen‐Chun Liu

Wen‐Chun Liu is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 148 papers that have together received 5.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (43 papers), Hepatitis B Virus Studies (38 papers) and HIV/AIDS drug development and treatment (37 papers). The work is most often cited by research in Infectious Diseases (3.0k citations), Virology (395 citations) and Hepatology (652 citations). Wen‐Chun Liu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Randy A. Albrecht, Jean K. Lim, Tristan X. Jordan, Taia T. Wang, Kohei Oishi, Maryline Panis, Robert E. Schwartz, Daniel Blanco-Melo, David Sachs and Benjamin E. Nilsson-Payant. Their work appears in journals such as Cell, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact